Search

Reset Filter

199 search results for ‘*’

Outside the Lab Professional development

Introducing NextMinds

| Markella Loi | 6 min read

Isabelle Kohler explains why she launched a mentoring platform designed for early-career scientists


Disease Area Respiratory

Take MIE Breath Away

| Markella Loi | 3 min read

Meet the micro-immunoelectrode biosensor that enables noninvasive detection of SARS-CoV-2 – in less than a minute


Tools & Techniques Drug delivery

Bladder Runner

| Rob Coker | 2 min read

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent


Research Field Drug discovery

Release the Beast

| Pandora Pound | 5 min read

The FDA Modernization Act opens the door for more innovative alternatives to animal testing for drug discovery and development

Research Field Drug discovery

Biologically Driven

| 4 min read

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Research Field Drug discovery

Opiate Dreams and Nightmares

| Jamie Irvine | 3 min read

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

Research Field Drug discovery

Minds, Interrupted

| Alex Fornito, Ashlea Segal | 2 min read

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

Research Field Drug discovery

Alzheimer’s Disease: The Winds of Progress

| Jamie Irvine | 10 min read

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

Research Field Drug discovery

The PEPITEM Pathway – and the Path to New Obesity Treatments

| Stephanie Vine | 6 min read

The world needs new medicines to treat obesity-related conditions. Here’s what researchers at the UK’s University of Birmingham are doing about it.

Research Field Drug discovery

Honey, I Shrunk the Molecules

| Jamie Irvine | 2 min read

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register